CYTOMEGALOVIRUS ISOLATE RESISTANT TO GANCICLOVIR AND FOSCARNET FROM A MARROW TRANSPLANT PATIENT

被引：92

作者：

KNOX, KK

DROBYSKI, WR

CARRIGAN, DR

机构：

[1] MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53226

[2] MED COLL WISCONSIN,BONE MARROW TRANSPLANT PROGRAM,MILWAUKEE,WI 53226

来源：

LANCET | 1991年 / 337卷 / 8752期

关键词：

D O I：

10.1016/0140-6736(91)92965-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1292 / 1293

页数：2

相关论文

共 9 条

[1] BIRCH CJ, 1989, J INFECT DIS, V162, P731
[2] DERSE D, 1982, J BIOL CHEM, V257, P251
[3] DROBYSKI WR, IN PRESS TRANSPLANTA
[4] PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS
ERICE, A
CHOU, S
BIRON, KK
STANAT, SC
BALFOUR, HH
JORDAN, MC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) : 289 - 293
[5] FRANK KB, 1982, ANTIMICROB AGENTS CH, V27, P445
[6] INCREASED EFFICACY OF GANCICLOVIR IN COMBINATION WITH FOSCARNET AGAINST CYTOMEGALOVIRUS AND HERPES-SIMPLEX VIRUS TYPE-2 INVITRO AND INVIVO
FREITAS, VR
FRASERSMITH, EB
MATTHEWS, TR
[J]. ANTIVIRAL RESEARCH, 1989, 12 (04) : 205 - 212
[7] HIV WITH REDUCED SENSITIVITY TO ZIDOVUDINE (AZT) ISOLATED DURING PROLONGED THERAPY
LARDER, BA
DARBY, G
RICHMAN, DD
[J]. SCIENCE, 1989, 243 (4899) : 1731 - 1734
[8] SYNERGISTIC EFFECT OF GANCICLOVIR AND FOSCARNET ON CYTOMEGALOVIRUS REPLICATION INVITRO
MANISCHEWITZ, JF
QUINNAN, GV
LANE, HC
WITTEK, AE
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) : 373 - 375
[9] PARKER AC, 1987, LANCET, V2, P1461